Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

119.00p
   
  • Change Today:
      2.50p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.81m
  • Volume: 12,199
  • Market Cap: £100.93m
  • RiskGrade: 196
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
72.95% above the market average72.95% above the market average72.95% above the market average72.95% above the market average72.95% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
12.03% above the market average12.03% above the market average12.03% above the market average12.03% above the market average12.03% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Book Ratio
52.09% below the market average52.09% below the market average52.09% below the market average52.09% below the market average52.09% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
60.87% below the market average60.87% below the market average60.87% below the market average60.87% below the market average60.87% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Price Chg 3m
19.76% below the market average19.76% below the market average19.76% below the market average19.76% below the market average19.76% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
36.87% below the market average36.87% below the market average36.87% below the market average36.87% below the market average36.87% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Momentum 20
72.63% below the market average72.63% below the market average72.63% below the market average72.63% below the market average72.63% below the market average
81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
51.99% below the market average51.99% below the market average51.99% below the market average51.99% below the market average51.99% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.16% below the market average68.16% below the market average68.16% below the market average68.16% below the market average68.16% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
12.14% below the market average12.14% below the market average12.14% below the market average12.14% below the market average12.14% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Operating Profit Loss
60.21% below the market average60.21% below the market average60.21% below the market average60.21% below the market average60.21% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.04% above the market average3.04% above the market average3.04% above the market average3.04% above the market average3.04% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Cash
14.26% above the market average14.26% above the market average14.26% above the market average14.26% above the market average14.26% above the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.91% above the market average18.91% above the market average18.91% above the market average18.91% above the market average18.91% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Buys 1y
69.23% below the market average69.23% below the market average69.23% below the market average69.23% below the market average69.23% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 119.00p
Change Today 2.50p
% Change 2.15 %
52 Week High 150.00
52 Week Low 108.00
Volume 12,199
Shares Issued 84.81m
Market Cap £100.93m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Price Trend
18.16% below the market average18.16% below the market average18.16% below the market average18.16% below the market average18.16% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Income Not Available
Growth
44.93% above the market average44.93% above the market average44.93% above the market average44.93% above the market average44.93% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Diaceutics Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:35 3,724 @ 119.00p
16:35 3,724 @ 119.00p
14:53 416 @ 118.50p
14:17 3,000 @ 118.40p
12:26 4,238 @ 118.40p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page